EP 3963092 A1 20220309 - SOMATIC CANCER DRIVER MUTATIONS IN ENDOMETRIOSIS LESIONS CONTRIBUTE TO SECONDARY CANCER RISK
Title (en)
SOMATIC CANCER DRIVER MUTATIONS IN ENDOMETRIOSIS LESIONS CONTRIBUTE TO SECONDARY CANCER RISK
Title (de)
SOMATISCHE KREBSTREIBERMUTATIONEN IN ENDOMETRIOSELÄSIONEN, DIE ZU EINEM SEKUNDÄREN KREBSRISIKO BEITRAGEN
Title (fr)
CONTRIBUTION À UN RISQUE DE CANCER SECONDAIRE DE MUTATIONS SOMATIQUES DE FACTEURS DU CANCER DANS LES LÉSIONS D'ENDOMÉTRIOSE
Publication
Application
Priority
- US 201962842064 P 20190502
- US 201962842060 P 20190502
- US 201962842061 P 20190502
- US 201962842066 P 20190502
- US 2020031089 W 20200501
Abstract (en)
[origin: WO2020223657A1] Disclosed herein are methods of diagnosing one or more conditions, including endometriosis, cancer, or a combination thereof. The methods may also include identifying a likelihood or risk of developing one or more conditions. Disclosed herein are methods and compositions for treating one or more conditions, such as by administering one or more pharmaceutical compositions in unit dose form. The treating may include prophylactic treating. Methods may include detecting one or more mutations in a genetic material obtained from a subject, such as a subject in need thereof.
IPC 8 full level
C12Q 1/68 (2018.01); G01N 33/574 (2006.01)
CPC (source: EP)
C12Q 1/6883 (2013.01); C12Q 1/6886 (2013.01); C12Q 2600/156 (2013.01)
Citation (search report)
See references of WO 2020223657A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
DOCDB simple family (application)
US 2020031089 W 20200501; EP 20799047 A 20200501